Evidence map›Paper›PMID 31028201›Full record

ArticleIn vivo (Athens, Greece)

The Evaluation of Glutathione Reductase and Malondialdehyde Levels in Patients With Lumbar Disc Degeneration Disease.

Selvi Duman Bakirezer, Cumhur Kaan Yaltirik, Ahmet Hilmi Kaya, Seda Gulec Yilmaz, Selcuk Ozdogan, Deryanaz Billur, Turgay Isbir

Open access · diamondAbstract read
In one paragraph

Article in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Lipid Peroxidation, Reduced Glutathione, and Glutathione Peroxidase Levels in Intervertebral Discs of Patients with Lumbar Degenerative Disc Disease.Medical science monitor : international medical journal of experimental and clinical research · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Selvi Duman BakirezerDepartment of Molecular Medicine, Institute of Health Sciences, Yeditepe University, Istanbul, Turkey dumanselvi@hotmail.com selvi.duman@yeditepe.edu.tr.
Cumhur Kaan YaltirikDepartment of Neurosurgery, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.
Ahmet Hilmi KayaDepartment of Neurosurgery, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.
Seda Gulec YilmazDepartment of Molecular Medicine, Institute of Health Sciences, Yeditepe University, Istanbul, Turkey.
Selcuk OzdoganSancaktepe Sehit Prof Dr İlhan Varank Training and Research Hospital, Istanbul, Turkey.
Deryanaz BillurDepartment of Molecular Medicine, Institute of Health Sciences, Yeditepe University, Istanbul, Turkey.
Turgay IsbirDepartment of Medical Biology, Faculty of Medicine, Yeditepe University, Istanbul, Turkey.
Yeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

aimIncreased oxidative stress plays a crucial role in pathogenesis of various diseases. The present study aims to investigate glutathione reductase (GR) and malondialdehyde (MDA) enzymes as markers of oxidative stress mechanisms in lumbar disc degeneration disease (LDDD). PATIENTS AND

methodsThe study group consisted of 39 patients diagnosed with LDD and 37 healthy individuals in the control group. The enzyme-linked immunosorbent assay (ELISA) method was used to determine serum GR and MDA levels in the two study groups.

resultsSerum GR levels were significantly lower (p=0.008), while MDA levels were significantly higher in the patient group compared to the controls (p=0.025).

conclusionOxidative stress mechanisms play a crucial role in disc degeneration and GR deficiency could be an eligible risk factor for LDDD.

Indexed as

AdultBiomarkersCase-Control StudiesFemaleGlutathione ReductaseHumansIntervertebral Disc DegenerationLumbar VertebraeMaleMalondialdehydeMiddle AgedBiomarkersGlutathione ReductaseMalondialdehydebiomarkerglutathione reductaseLumbar disc degenerationmalondialdehyde

Identifiers

PMID31028201
PMCPMC6559890
OpenAlexW2942423344

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.